ClinicalTrials.Veeva

Menu

Treatment of Post-Operative Pain Following Orthopedic Surgery With SPRINT® Peripheral Nerve Stimulation (PNS) System

S

SPR Therapeutics

Status

Completed

Conditions

Postoperative Pain
Partial Knee Replacement
Total Knee Arthroplasty
Total Knee Replacement

Treatments

Device: SPRINT Peripheral Nerve Stimulation (PNS) System

Study type

Interventional

Funder types

Industry
Other U.S. Federal agency

Identifiers

NCT04341948
CDMRP-OR170165 (Other Grant/Funding Number)
0150-CSP-000

Details and patient eligibility

About

The purpose of this study is to gather information about how knee pain changes when small amounts of electricity are delivered to the nerves in the leg. This study will involve the use of a Peripheral Nerve Stimulation (PNS) System that is made by SPR Therapeutics (the sponsor of the study). The SPRINT PNS System was cleared by the FDA for up to 60 days of use in the back and/or extremities for the management of acute and chronic pain.

Enrollment

56 patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

  • At least 21 years old
  • Underwent a 1. primary total knee replacement (TKR), 2. secondary/revision TKR or 3. Partial/unicompartmental knee replacement (PKR)
  • Knee pain directly resulting from Knee Replacement surgery in affected knee

Key Exclusion Criteria:

  • Current high opioid use
  • Body Mass Index (BMI) > 40 kg/m2
  • Conditions with increased risk of infection
  • Implanted electronic device
  • History of bleeding or clotting disorder.
  • Uncontrolled Diabetes Mellitus Types I or II
  • Pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

56 participants in 2 patient groups

Group 1 (Treatment)
Active Comparator group
Description:
Participants in Group 1 will have Leads placed by the nerves of the mid to upper thigh. These participants will then use the SPRINT Peripheral Nerve Stimulation (PNS) System and will receive electrical stimulation for 8 weeks.
Treatment:
Device: SPRINT Peripheral Nerve Stimulation (PNS) System
Group 2 (Control)
Sham Comparator group
Description:
Participants in Group 2 will have Leads placed by the nerves of the mid to upper thigh. These participants will then use the SPRINT Peripheral Nerve Stimulation (PNS) System and receive 8 weeks of sham stimulation. Participants will then have the option to crossover and receive stimulation therapy.
Treatment:
Device: SPRINT Peripheral Nerve Stimulation (PNS) System

Trial contacts and locations

10

Loading...

Central trial contact

Ryan Begun

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems